Assertio Holdings Inc (ASRT)
1.05
+0.01
(+0.96%)
USD |
NASDAQ |
Jun 14, 16:00
1.045
0.00 (0.00%)
After-Hours: 20:00
Assertio Holdings Accounts Payable (Quarterly): 15.65M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 15.65M |
December 31, 2023 | 13.44M |
September 30, 2023 | 19.00M |
June 30, 2023 | 11.18M |
March 31, 2023 | 6.173M |
December 31, 2022 | 5.991M |
September 30, 2022 | 8.374M |
June 30, 2022 | 9.415M |
March 31, 2022 | 8.523M |
December 31, 2021 | 6.685M |
September 30, 2021 | 7.666M |
June 30, 2021 | 16.48M |
March 31, 2021 | 10.61M |
December 31, 2020 | 14.81M |
September 30, 2020 | 22.98M |
June 30, 2020 | 28.54M |
March 31, 2020 | 4.982M |
December 31, 2019 | 16.19M |
September 30, 2019 | 22.70M |
June 30, 2019 | 2.188M |
March 31, 2019 | 5.421M |
December 31, 2018 | 6.138M |
September 30, 2018 | 17.39M |
June 30, 2018 | 3.144M |
March 31, 2018 | 10.20M |
Date | Value |
---|---|
December 31, 2017 | 14.73M |
September 30, 2017 | 7.033M |
June 30, 2017 | 12.41M |
March 31, 2017 | 7.176M |
December 31, 2016 | 14.86M |
September 30, 2016 | 29.69M |
June 30, 2016 | 33.04M |
March 31, 2016 | 22.58M |
December 31, 2015 | 12.80M |
September 30, 2015 | 14.06M |
June 30, 2015 | 11.23M |
March 31, 2015 | 2.439M |
December 31, 2014 | 2.088M |
September 30, 2014 | 1.34M |
June 30, 2014 | 2.37M |
March 31, 2014 | 1.916M |
December 31, 2013 | 2.232M |
September 30, 2013 | 2.544M |
June 30, 2013 | 0.866M |
March 31, 2013 | 4.115M |
December 31, 2012 | 2.36M |
September 30, 2012 | 2.857M |
June 30, 2012 | 2.857M |
March 31, 2012 | 3.782M |
December 31, 2011 | 2.417M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.188M
Minimum
Jun 2019
28.54M
Maximum
Jun 2020
12.58M
Average
10.90M
Median
Accounts Payable (Quarterly) Benchmarks
Nektar Therapeutics | 8.757M |
Vertex Pharmaceuticals Inc | 351.40M |
Verastem Inc | 7.449M |
Cara Therapeutics Inc | 4.978M |
Ocugen Inc | 1.731M |